Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2003.029835v1, 2004; 10.1373/clinchem.2003.029835
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.029835v1
50/6/1002    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Hahn*, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Hahn*, S.

Received on November 27, 2003
Accepted on March 24, 2004

Molecular Diagnostics and Genetics

Size Separation of Circulatory DNA in Maternal Plasma Permits Ready Detection of Fetal DNA Polymorphisms

Ying Li 1, Bernhard Zimmerman 1, Corinne Rusterholz 1, Anjeung Kang 1, Wolfgang Holzgreve 1, Sinuhe Hahn* 1

1 University Women’s Hospital/Department of Research, University of Basel, Basel, Switzerland

Background: Analysis of fetal DNA in maternal plasma has recently been introduced as a new method for noninvasive prenatal diagnosis, particularly for the analysis of fetal genetic traits, which are absent from the maternal genome, e.g., RHD or Y-chromosome-specific sequences. To date, the analysis of other fetal genetic traits has been more problematic because of the overwhelming presence of maternal DNA sequences in the circulation. We examined whether different biochemical properties can be discerned between fetal or maternal circulatory DNA.

Methods: Plasma DNA was examined by agarose gel electrophoresis. The fractions of fetal and maternal DNA in size-fractionated fragments were assayed by real-time PCR. The determination of paternally and maternally inherited fetal genetic traits was examined by use of highly polymorphic chromosome-21-specific microsatellite markers.

Results: Size fractionation of circulatory DNA indicated that the major portion of cell-free fetal DNA had an approximate molecular size of <0.3 kb, whereas maternally derived sequences were, on average, considerably larger than 1 kb. Analysis of size-fractionated DNA (<=0.3 kb) from maternal plasma samples facilitated the ready detection of paternally and maternally inherited microsatellite markers.

Conclusions: Circulatory fetal DNA can be enriched by size selection of fragment sizes less than ~0.3kb. Such selection permits easier analysis of both paternally and maternally inherited DNA polymorphisms.




The following articles in journals at HighWire Press have cited this article:


Home page
Hum Reprod UpdateHome page
C. F. Wright and H. Burton
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
Hum. Reprod. Update, January 1, 2009; 15(1): 139 - 151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. F. Orozco, C. J. Jorgez, C. Horne, D. A. Marquez-Do, M. R. Chapman, J. R. Rodgers, F. Z. Bischoff, and D. E. Lewis
Membrane Protected Apoptotic Trophoblast Microparticles Contain Nucleic Acids: Relevance to Preeclampsia
Am. J. Pathol., December 1, 2008; 173(6): 1595 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake
From the Cover: Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
PNAS, October 21, 2008; 105(42): 16266 - 16271.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Mamon, C. Hader, J. Li, L. Wang, M. Kulke, G. Amicarelli, E. Shehi, D. Adlerstein, K. Roper, L. Killion, et al.
Preferential Amplification of Apoptotic DNA from Plasma: Potential for Enhancing Detection of Minor DNA Alterations in Circulating DNA
Clin. Chem., September 1, 2008; 54(9): 1582 - 1584.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. M. Dennis Lo and R. W. K. Chiu
Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidies by Maternal Plasma Nucleic Acid Analysis
Clin. Chem., March 1, 2008; 54(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. M. D. Lo, F. M. F. Lun, K. C. A. Chan, N. B. Y. Tsui, K. C. Chong, T. K. Lau, T. Y. Leung, B. C. Y. Zee, C. R. Cantor, and R. W. K. Chiu
From the Cover: Digital PCR for the molecular detection of fetal chromosomal aneuploidy
PNAS, August 7, 2007; 104(32): 13116 - 13121.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
O. Lapaire, D. W. Bianchi, I. Peter, B. O'Brien, H. Stroh, J. M. Cowan, U. Tantravahi, and K. L. Johnson
Cell-Free Fetal DNA in Amniotic Fluid: Unique Fragmentation Signatures in Euploid and Aneuploid Fetuses
Clin. Chem., March 1, 2007; 53(3): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Li, W. Holzgreve, V. Kiefer, and S. Hahn
MALDI-TOF Mass Spectrometry Compared With Real-Time PCR for Detection of Fetal Cell-Free DNA in Maternal Plasma
Clin. Chem., December 1, 2006; 52(12): 2311 - 2312.
[Full Text] [PDF]


Home page
Mol Hum ReprodHome page
I. Stanghellini, R. Bertorelli, L. Capone, V. Mazza, C. Neri, A. Percesepe, and A. Forabosco
Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe
Mol. Hum. Reprod., September 1, 2006; 12(9): 587 - 591.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. J. Huang, B. G. Zimmermann, W. Holzgreve, and S. Hahn
Use of an Automated Method Improves the Yield and Quality of Cell-Free Fetal DNA Extracted from Maternal Plasma
Clin. Chem., December 1, 2005; 51(12): 2419 - 2420.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
B. C.K. Wong, R. W.K. Chiu, N. B.Y. Tsui, K.C. A. Chan, L. W. Chan, T. K. Lau, T. N. Leung, and Y.M. D. Lo
Circulating Placental RNA in Maternal Plasma Is Associated with a Preponderance of 5' mRNA Fragments: Implications for Noninvasive Prenatal Diagnosis and Monitoring
Clin. Chem., October 1, 2005; 51(10): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Zimmermann, A. El-Sheikhah, K. Nicolaides, W. Holzgreve, and S. Hahn
Optimized Real-Time Quantitative PCR Measurement of Male Fetal DNA in Maternal Plasma
Clin. Chem., September 1, 2005; 51(9): 1598 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K.C. A. Chan, S.-W. Yeung, W.-B. Lui, T. H. Rainer, and Y.M. D. Lo
Effects of Preanalytical Factors on the Molecular Size of Cell-Free DNA in Blood
Clin. Chem., April 1, 2005; 51(4): 781 - 784.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y.M. D. Lo
Recent Advances in Fetal Nucleic Acids in Maternal Plasma
J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. K. R. Chinnapapagari, W. Holzgreve, O. Lapaire, B. Zimmermann, and S. Hahn
Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal Plasma
Clin. Chem., March 1, 2005; 51(3): 652 - 655.
[Full Text] [PDF]


Home page
JAMAHome page
Y. Li, E. Di Naro, A. Vitucci, B. Zimmermann, W. Holzgreve, and S. Hahn
Detection of Paternally Inherited Fetal Point Mutations for {beta}-Thalassemia Using Size-Fractionated Cell-Free DNA in Maternal Plasma
JAMA, February 16, 2005; 293(7): 843 - 849.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Benachi, A. Yamgnane, M. Olivi, Y. Dumez, E. Gautier, and J.-M. Costa
Impact of Formaldehyde on the in Vitro Proportion of Fetal DNA in Maternal Plasma and Serum
Clin. Chem., January 1, 2005; 51(1): 242 - 244.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.